Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 605

1.

Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease.

Sarratt SC, Nesbit R, Moye R.

Ann Pharmacother. 2017 Jun;51(6):445-450. doi: 10.1177/1060028017694654. Epub 2017 Feb 1.

PMID:
28478715
2.

Risk of Gastrointestinal Bleeding in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants: a Systematic Review and Meta-analysis.

Miller CS, Dorreen A, Martel M, Huynh T, Barkun AN.

Clin Gastroenterol Hepatol. 2017 Apr 27. pii: S1542-3565(17)30523-2. doi: 10.1016/j.cgh.2017.04.031. [Epub ahead of print]

PMID:
28458008
3.

Extended anticoagulation in venous thromboembolism disease. In favour.

Fernández Capitan MC.

Rev Clin Esp. 2017 Apr 12. pii: S0014-2565(17)30097-8. doi: 10.1016/j.rce.2017.02.017. [Epub ahead of print] English, Spanish.

PMID:
28411864
4.

Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.

Klok FA, Schreiber K, Stach K, Ageno W, Middeldorp S, Eichinger S, Delluc A, Blondon M, Ay C.

Thromb Res. 2017 May;153:101-107. doi: 10.1016/j.thromres.2017.03.013. Epub 2017 Mar 20.

PMID:
28376343
5.

Reversing the anticoagulation effects of dabigatran.

Dager WE, Banares L.

Hosp Pract (1995). 2017 Apr;45(2):29-38. doi: 10.1080/21548331.2017.1298389. Epub 2017 Mar 24. Review.

PMID:
28335637
6.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators..

N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18.

PMID:
28316279
7.

Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.

Shaw J, de Wit C, Le Gal G, Carrier M.

J Thromb Haemost. 2017 May;15(5):925-930. doi: 10.1111/jth.13670. Epub 2017 Apr 3.

PMID:
28296069
8.

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.

Sterne JA, Bodalia PN, Bryden PA, Davies PA, López-López JA, Okoli GN, Thom HH, Caldwell DM, Dias S, Eaton D, Higgins JP, Hollingworth W, Salisbury C, Savović J, Sofat R, Stephens-Boal A, Welton NJ, Hingorani AD.

Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090.

PMID:
28279251
9.

Gender differences in patients with venous thromboembolism and five common sites of cancer.

Martín-Martos F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, Lorenzo A, Barillari G, Soler S, Mahè I, Sahuquillo JC, Monreal M; RIETE Investigators..

Thromb Res. 2017 Mar;151 Suppl 1:S16-S20. doi: 10.1016/S0049-3848(17)30061-0.

PMID:
28262228
10.

Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.

Tzoran I, Papadakis E, Brenner B, Valle R, López-Jiménez L, García-Bragado F, Riera-Mestre A, Villalobos A, Quintavalla R, Monreal M; RIETE Investigators..

Thromb Res. 2017 Mar;151 Suppl 1:S11-S15. doi: 10.1016/S0049-3848(17)30060-9.

PMID:
28262227
11.

Uterine bleeding during anticoagulation in women with venous thromboembolism.

Moustafa F, Fernández S, Fernández-Capitán C, Nieto JA, Pedrajas JM, Visoná A, Valero B, Marchena PJ, Braester A, Monreal M; RIETE Investigators..

Thromb Res. 2017 Mar;151 Suppl 1:S1-S5. doi: 10.1016/S0049-3848(17)30058-0.

PMID:
28262225
12.

Timing of anticoagulant re-initiation following intracerebral hemorrhage in mechanical heart valves: Survey of neurosurgeons and thrombosis experts.

AlKherayf F, Xu Y, Westwick H, Moldovan ID, Wells PS.

Clin Neurol Neurosurg. 2017 Mar;154:23-27. doi: 10.1016/j.clineuro.2017.01.006. Epub 2017 Jan 16.

PMID:
28103532
13.

[Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?]

Buerke M, Hoffmeister HM.

Med Klin Intensivmed Notfmed. 2017 Mar;112(2):105-110. doi: 10.1007/s00063-016-0240-2. Epub 2017 Jan 10. German.

PMID:
28074293
14.

Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.

Ross JA, Miller MM, Rojas Hernandez CM.

Thromb Res. 2017 Feb;150:86-89. doi: 10.1016/j.thromres.2016.12.016. Epub 2016 Dec 22.

PMID:
28064037
15.

Mobile pump deep vein thrombosis prophylaxis: just say no to drugs.

Haynes J, Barrack RL, Nam D.

Bone Joint J. 2017 Jan;99-B(1 Supple A):8-13. doi: 10.1302/0301-620X.99B1.BJJ-2016-0165.R1.

PMID:
28042112
16.

Best Clinical Practice: Controversies in Outpatient Management of Acute Pulmonary Embolism.

Long B, Koyfman A.

J Emerg Med. 2017 May;52(5):668-679. doi: 10.1016/j.jemermed.2016.11.020. Epub 2016 Dec 19.

PMID:
28007362
17.

Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.

Tzoran I, Papadakis M, Brenner B, Fidalgo Á, Rivas A, Wells PS, Gavín O, Adarraga MD, Moustafa F, Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators..

Am J Med. 2017 Apr;130(4):482.e1-482.e9. doi: 10.1016/j.amjmed.2016.11.016. Epub 2016 Dec 14.

PMID:
27986523
18.

Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry.

Königsbrügge O, Simon A, Domanovits H, Pabinger I, Ay C.

BMC Cardiovasc Disord. 2016 Dec 9;16(1):254.

PMID:
27938343
19.

Pharmacological management of pulmonary embolism.

Gouin B, Robert-Ebadi H, Righini M, Blondon M.

Expert Opin Pharmacother. 2017 Jan;18(1):79-93. doi: 10.1080/14656566.2016.1268122. Review.

PMID:
27917690
20.

Thrombosis and anticoagulation in the setting of renal or liver disease.

Ribic C, Crowther M.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):188-195. Review.

PMID:
27913479

Supplemental Content

Loading ...
Support Center